- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03940547
Mycotoxin Mitigation Trial (MMT)
Trial to Establish Causal Linkage Between Mycotoxin Exposure and Child Stunting
Multiple observational studies show an association between fetal and post-natal aflatoxin exposure and reduced linear growth. However, the effects of confounding factors such as socio-economic status, food insecurity and nutrient deficiencies due to monotonous diets have not been ruled out. This trial will quantify the causal role of infant aflatoxin ingestion on post-natal growth by performing a cluster randomized trial in children 6-18 months of age in the Dodoma Region of Tanzania.
All health facilities in one district in Dodoma will be randomized to the control or intervention arm. Infants will be recruited into the study over one year to account for seasonal variation in AF exposure. Both arms will receive infant and young child feeding education, a thermos flask and plastic measuring scoops. The intervention arm will receive a low-aflatoxin pre-blended porridge flour containing maize and groundnut (ratio 4:1 respectively) and low-aflatoxin groundnut flour, whereas in the control arm the same porridge mix will be promoted through education, but acquired by the household. The primary outcome is length-for-age Z-score at 18 months.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective of this study is to determine the effect of a very low AF complementary feeding intervention on LAZ using a cluster randomized design (CRT), while promoting a nutritionally adequate diet to all infants between 6-18 months of age. The hypothesis is that ingestion of AF can reduce infant length and that a reduction of AF exposure will result in improved length for age z-scores (LAZ). The primary outcome is LAZ, which will be measured at 18 months.
The unit of randomization is government-run health facilities (health centers, dispensaries and hospital, 52 clusters in total) in the Kongwa District. Mothers and infants will be recruited into the trial based on 42 day EPI visit attendance, which has very high (>95%) coverage in Kongwa District. Recruitment of infants will be performed for one complete calendar year capture variability in exposure by season.
Critical to casual inference is the intervention's ability to create a contrast of AF consumption between the control and intervention groups, without creating differential macro- or micro-nutrient intake or differences in feeding and care practices that could affect stunting between arms. To reduce the risk of introducing these biases, the investigators designed the intervention to include: 1) education to improve infant feeding and care practices in both arms, and 2) behavior change communication on the use of blended infant porridge flours in both arms. Participants in the intervention group will receive low-aflatoxin blended infant porridge flour and groundnut flour, made in accordance with Tanzanian food and mycotoxin regulations. Those in the control group will not receive any flour, but will be advised to feed their infants a blend similar in ingredients and ratio to what the intervention group will receive. Both groups will receive a thermos flask to store porridge and a small plastic measuring scoop to measure porridge flour for preparation of the porridge.
The sample size was calculated using a one-sided test of independent sample means, with a standard deviation of 1.2 Z, type I error of 0.05, power of 0.90, design effect of 2.0 and assuming a coefficient of variation of .144 for varying cluster size, based on previous year's data for EPI attendance at 42 days. Given these parameters our total sample size is calculated to be 2,322 (1,161 infants per cluster). Conservatively estimating a 20% loss to follow-up and infant mortality, the total number of infants is 2,787, or 54 infants recruited per health cluster annually or 4.5 infants per cluster per month. Rounding up, 5 infants per cluster each month will be recruited for a total of 3,120 potential infants, recognizing that in approximately 6 of the health facilities, it is unlikely that all 60 infants because of the size of the population served by the facility.
The trial will be conducted in the Kongwa District of Dodoma, Tanzania, where the investigators have performed formative research (Protocol Identification#: 1703007043) and confirmed AF contamination in local foods, primarily groundnuts, and that infants are exposed to aflatoxin. The frequency and level of exposure is similar in range to the West African observational studies. Kongwa District is a good location to perform this study, as exposure is high enough to be suspected of contributing to stunting, but low enough as to not cause aflatoxicosis.
NOTE: Data collection was stopped between April 9 and June 8, 2020 due to the SARS-CoV-2 outbreak, in accordance with the guidance of the Tanzanian National Institute for Medical Research. The delivery of the intervention continued during this time.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Dodoma
-
Kongwa, Dodoma, Tanzania
- Kongwa District Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
1. Babies >6 weeks old and <4 months old, who seek Expanded Program on Immunization (EPI) from a randomized health facility and reside in Kongwa District
Exclusion Criteria, assessed at recruitment and again at the 6-month visit:
- Babies with disabilities that preclude normal feeding and swallowing
- Refusal to consent to assigned intervention
- An infant who has shown signs of a potential groundnut allergy (assessed the first time mother reports groundnut consumption)
- An infant who is a twin
- If the mother plans to travel for more than 2 months at or after the randomized intervention begins
- If the mother is below 16 years of age
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental - provision of flour
This arm will receive infant and young child feeding education performed by community health workers and very-low aflatoxin (AF) pre-blended porridge flour, ratio 4:1 maize to groundnut.
Provision of this pre-blended flour will be 50 grams/day for 6-8 month olds, 60/day grams for 9-11 months and 75 grams/day for 12-18 month olds (with 10-15 grams added per day to account for any loss).
Participants will also receive 1 kg of low-AF groundnut flour each month for 6-18 month olds.
Finally, participants will receive a thermos flask to hygienically store porridge and a plastic scoop to measure appropriate amount of porridge flour each day.
|
Infant and young child feeding education and provision of low AF porridge and groundnut flours from 6-18 months
|
Active Comparator: Control - promotion of flour
This arm will receive infant and young child feeding education performed by community health workers and promotion of porridge made from maize and groundnut to match what is provided to the intervention arm.
Participants will also receive a thermos flask to hygienically store porridge and a plastic scoop to measure appropriate amount of porridge flour each day.
|
Infant and young child feeding education and promotion of porridge and groundnut flours from 6-18 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Linear growth
Time Frame: 18 months
|
Length for age Z score
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Linear growth
Time Frame: 12 months
|
Length for age Z score
|
12 months
|
Prevalence of stunting
Time Frame: 12 and 18 months
|
Prevalence of stunting (<-2 LAZ)
|
12 and 18 months
|
Ponderal growth
Time Frame: 12 and 18 months
|
Weight for age Z score
|
12 and 18 months
|
Prevalence of underweight
Time Frame: 12 and 18 months
|
Prevalence of underweight (<-2 WAZ)
|
12 and 18 months
|
Concentration of urinary biomarker
Time Frame: 9, 12, 15, 18 months
|
Concentration of aflatoxin M1 (AFM1) urinary biomarker
|
9, 12, 15, 18 months
|
Concentration of AF blood biomarker
Time Frame: 12 and 18 months
|
Concentration of AF blood biomarker AF-alb
|
12 and 18 months
|
Middle-upper-arm circumference (MUAC)
Time Frame: 12 and 18 months in full sample; 9, 12, 15, 18 months in sub-samples
|
Middle-upper-arm circumference Z score
|
12 and 18 months in full sample; 9, 12, 15, 18 months in sub-samples
|
Head circumference
Time Frame: 12 and 18 months in full sample; 9, 12, 15, 18 months in sub-samples
|
Head-circumference-for-age Z score
|
12 and 18 months in full sample; 9, 12, 15, 18 months in sub-samples
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rebecca J Nelson, PhD, Cornell University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1809008284
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aflatoxin Ingestion
-
Montefiore Medical CenterWithdrawnCarnitine IngestionUnited States
-
Assiut UniversityRecruiting
-
University Hospital, GhentRecruitingIntoxication | Unintended Ingestion of ProductBelgium
-
University of BathCompletedExercise Metabolism Following Ethanol IngestionUnited Kingdom
-
Université de MontréalFédération des producteurs acéricoles du QuébecCompletedAthletic Performance | Carbohydrate Ingestion | Fuel SelectionCanada
-
Dr. med. Mahir KarakasCompletedBiotin Ingestion | Interference With Routine Analyical TestsGermany
-
Université de MontréalFédération des producteurs acéricoles du QuébecCompletedHigh Intensity Interval Training | Cognitive Performance | Carbohydrate IngestionCanada
-
Maastricht University Medical CenterCompletedAcute Nitrate Ingestion on Athletic PerformanceNetherlands
-
University Hospitals Cleveland Medical CenterMelissa March; Alison Bauer; Gaetan Pettigrew; Daisy Hassani; Celina CunananWithdrawnEffect of Carbohydrate Ingestion During Active Labor
-
University of LimerickMarigot Ltd.; Enterprise IrelandCompletedBioavailability of Amino Acids Following Oral Ingestion of Plant-Based Proteins in Young, Healthy MenIreland
Clinical Trials on Provision of flour
-
Mexican National Institute of Public HealthCompleted
-
Massachusetts General HospitalNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of PennsylvaniaNational Institute on Aging (NIA)Completed
-
University of California, San DiegoRecruiting
-
Federal University of Minas GeraisCompleted
-
South Dakota State UniversityCompleted
-
Boston Children's HospitalNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Technical University of MunichBavarian State Ministry of Health and Care; German Alzheimer SocietyCompleted
-
London School of Hygiene and Tropical MedicineEmory University; University of California, Davis; Bill and Melinda Gates Foundation and other collaboratorsCompletedNutritional Status | Diarrhoea | Soil-transmitted Helminth InfectionIndia
-
University of NottinghamCompleted